Suppr超能文献

持续输注与大剂量注射袢利尿剂治疗充血性心力衰竭患者的Meta分析

Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis.

作者信息

Karedath Jithin, Asif Anim, Tentu Niharika, Zahra Tafseer, Batool Saima, Sathish Meenakshi, Sandhu Qudsia I, Khan Areeba

机构信息

Internal Medicine, James Cook University Hospital, Middlesbrough, GBR.

Medicine, Fauji Foundation, Rawalpindi, PAK.

出版信息

Cureus. 2023 Feb 8;15(2):e34758. doi: 10.7759/cureus.34758. eCollection 2023 Feb.

Abstract

Loop diuretics continue to be a crucial component of pharmacological treatment, to eliminate extra fluid and enhance symptom control in acute decompensated heart failure (ADHF). Understanding the loop diuretics' more efficient form of administration would be very beneficial in improving the management of people's ADHF, resulting in a quicker resolution of symptoms and a notable decrease in morbidity. To assess the outcomes of intravenous continuous infusion with bolus injection of loop diuretics for patients with ADHF, this meta-analysis was carried out. The current meta-analysis was conducted as per the Cochrane Collaboration guidelines and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension (PRISMA) guidelines. A search was carried out on PubMed and EMBASE databases for studies comparing continuous infusion with intermittent bolus injection of furosemide in patients with congestive heart failure without restriction on the language of publication from 1 January 2001 to 31 July 2022. The primary outcome of the meta-analysis was all-cause mortality and loss of body weight (kg). Pre-defined secondary outcomes included length of hospital stay (LOS) in days, brain natriuretic peptide (BNP) reduction (pg/ml), number of patients with hypokalemia, and urine output at 24 hours (ml). A total of nine articles were included in this meta-analysis enrolling 713 patients. No significant difference was reported between patients who received intermittent bolus injections and continuous infusion of furosemide in regards to all-cause mortality, LOS, total urine output, the incidence of hypokalemia, and change in BNP. However, the reduction of body weight was greater in the continuous infusion group compared to bolus administration. In conclusion, in the current meta-analysis of nine randomized controlled trials (RCTs), continuous infusion of furosemide seemed to have a greater reduction of body weight. However, no significant difference was there in 24-hrs urine output. However, we cannot conclude that intravenous continuous infusion has a better diuretic effect compared to bolus administration.

摘要

袢利尿剂仍然是药物治疗的关键组成部分,用于消除急性失代偿性心力衰竭(ADHF)患者体内的多余液体并增强症状控制。了解袢利尿剂更有效的给药方式对于改善ADHF患者的管理非常有益,可更快缓解症状并显著降低发病率。为了评估静脉持续输注与大剂量注射袢利尿剂对ADHF患者的治疗效果,进行了这项荟萃分析。本荟萃分析按照Cochrane协作组指南和系统评价与荟萃分析扩展版的首选报告项目(PRISMA)指南进行。在PubMed和EMBASE数据库中进行检索,以查找比较2001年1月1日至2022年7月31日期间充血性心力衰竭患者中持续输注与间歇性大剂量注射呋塞米的研究,对发表语言不做限制。荟萃分析的主要结局是全因死亡率和体重减轻(千克)。预先定义的次要结局包括住院天数(LOS)、脑钠肽(BNP)降低幅度(pg/ml)、低钾血症患者数量以及24小时尿量(毫升)。本荟萃分析共纳入9篇文章,涉及713例患者。在全因死亡率、LOS、总尿量、低钾血症发生率和BNP变化方面,接受间歇性大剂量注射和持续输注呋塞米的患者之间未报告有显著差异。然而,与大剂量给药相比,持续输注组的体重减轻幅度更大。总之,在当前对9项随机对照试验(RCT)的荟萃分析中,持续输注呋塞米似乎体重减轻幅度更大。然而,24小时尿量没有显著差异。然而,我们不能得出静脉持续输注比大剂量给药具有更好利尿效果的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5694/10005852/a581e2586e93/cureus-0015-00000034758-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验